相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of cell-free DNA in urine as a marker for bladder cancer diagnosis
Matelda Zancan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2017)
Urine Cell-Free DNA integrity as a marker for early bladder cancer diagnosis: Preliminary data
Valentina Casadio et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Prostate-Cancer Mortality at 11 Years of Follow-up
Fritz H. Schroder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Circulating mitochondrial DNA in serum: A universal diagnostic biomarker for patients with urological malignancies
Joerg Ellinger et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2012)
Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis
T. Wu et al.
BRITISH JOURNAL OF CANCER (2011)
Circulating tumour markers can define patients with normal colons, benign polyps, and cancers
R. Mead et al.
BRITISH JOURNAL OF CANCER (2011)
Amplification of the 20q Chromosomal Arm Occurs Early in Tumorigenic Transformation and May Initiate Cancer
Yuval Tabach et al.
PLOS ONE (2011)
Cell-free nucleic acids as biomarkers in cancer patients
Heidi Schwarzenbach et al.
NATURE REVIEWS CANCER (2011)
Serum Free Circulating DNA Is a Useful Biomarker to Distinguish Benign versus Malignant Prostate Disease
Edna Gordian et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Cell-free DNA in the blood as a solid tumor biomarker-A critical appraisal of the literature
Klaus Jung et al.
CLINICA CHIMICA ACTA (2010)
Prostate cancer screening: current status and future perspectives
Seth A. Strope et al.
NATURE REVIEWS UROLOGY (2010)
Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer
E. A. M. Heijnsdijk et al.
BRITISH JOURNAL OF CANCER (2009)
Screening for Prostate Cancer
Otis W. Brawley et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Cell-free Tumor DNA in Blood Plasma As a Marker for Circulating Tumor Cells in Prostate Cancer
Heidi Schwarzenbach et al.
CLINICAL CANCER RESEARCH (2009)
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
Stephen A. Bustin et al.
CLINICAL CHEMISTRY (2009)
Identification of a new prostate cancer susceptibility locus on chromosome 8q24
Meredith Yeager et al.
NATURE GENETICS (2009)
Screening and Prostate-Cancer Mortality in a Randomized European Study
Fritz H. Schroeder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
High-Resolution Array CGH Identifies Novel Regions of Genomic Alteration in Intermediate-Risk Prostate Cancer
Adrian S. Ishkanian et al.
PROSTATE (2009)
Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer
Annalisa Altimari et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators
Joerg Ellinger et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Serum free DNA and COX-2 mRNA expression in peripheral blood for lung cancer detection
P. Ulivi et al.
THORAX (2008)
Homozygous deletions and recurrent amplifications implicate new genes involved in prostate cancer
Wennuan Liu et al.
NEOPLASIA (2008)
DNA copy number alterations in prostate cancers: A combined analysis of published CGH studies
Jishan Sun et al.
PROSTATE (2007)
APTIMA PCA3 molecular urine test: Development of a method to aid in the diagnosis of prostate cancer
Jack Groskopf et al.
CLINICAL CHEMISTRY (2006)
High-resolution array comparative genomic hybridization of chromosome arm 8q:: Evaluation of genetic progression markers for prostate cancer
M van Duin et al.
GENES CHROMOSOMES & CANCER (2005)
Human urine contains small, 150 to 250 nucleotide-sized, soluble DNA derived from the circulation and may be useful in the detection of colorectal cancer
YH Su et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2004)
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative
PM Bossuyt et al.
CLINICAL CHEMISTRY (2003)
Her-2/neu oncogene amplification in clinically localised prostate cancer
JD Oxley et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
分享论文
